Małecki M, Krolewski A S
Katedra i Klinika Chorób Metabolicznych, Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
Przegl Lek. 2000;57 Suppl 3:13-8.
Type 2 diabetes is a complex disease and genetic as well as environmental factors play a role in its pathogenesis. Six different genes have been identified so far to be responsible for rare forms of autosomal dominant, early onset type 2 diabetes mellitus. All but one are transcription factors which influence expression of the other genes through the regulation of mRNA synthesis. These are hepatocyte nuclear factor (HNF)-4 alpha, HNF-1 alpha, insulin promoter factor (IPF)-1 and HNF-1 beta, which are associated with MODY1, 3, 4, 5 respectively. MODY1 is a relatively rare and usually severe form of diabetes. It is associated with progressive hyperglycemia and frequent chronic complications. The HNF-4 alpha gene is localized on chromosome 20q. Similar clinical characteristics apply to the MODY3 form, however the latter is much more frequent among early onset, autosomal dominant type 2 diabetes (20-40%). HNF-1 alpha gene is localized on chromosome 12q. HNF-1 beta (MODY5 locus on chromosome 17q) is a protein which forms heterodimers with HNF-1 alpha. This rare form of diabetes has a clinical picture similar to MODY1 and MODY3. It is sometimes accompanied by symptoms of early kidney damage which are independent from diabetes. The other two transcription factors responsible for the development of autosomal dominant type 2 diabetes are proteins which bind directly to the insulin promoter. MODY4 (IPF-1, chromosome 13q) is a rare form and of a typical middle and late onset type 2 diabetes. BETA 2/Neurod1 has been recently associated with MODY by Dr Krolewski's group from Joslin Diabetes Center, Boston, MA, USA. BETA 2 is responsible for about 2% of autosomal dominant type 2 diabetes. The clinical characteristics depend on the localization of the mutations in the specific functional domains of the protein. Mutations identified in the glucokinase gene are associated with the MODY2 form. Glucokinase is an enzyme involved in the first level of glucose metabolism in b-cells-enzymatic phosphorylation. MODY2 is a modest form of diabetes. It is characterized by mild hyper-glycemia, mainly fasting, and the chronic complications are very rare. Glucokinase gene is localized on chromosome 7p. It is expected that in the nearest future more type 2 susceptibility genes will be identified.
2型糖尿病是一种复杂的疾病,遗传因素和环境因素在其发病机制中均起作用。迄今为止,已确定6种不同的基因与罕见的常染色体显性、早发型2型糖尿病有关。除一种基因外,其余均为转录因子,它们通过调节mRNA合成来影响其他基因的表达。这些转录因子分别是肝细胞核因子(HNF)-4α、HNF-1α、胰岛素启动子因子(IPF)-1和HNF-1β,它们分别与青少年发病的成年型糖尿病(MODY)1、3、4、5相关。MODY1是一种相对罕见且通常较为严重的糖尿病类型。它与进行性高血糖和频繁的慢性并发症有关。HNF-4α基因位于20号染色体长臂(20q)上。MODY3也具有类似的临床特征,但在早发型常染色体显性2型糖尿病中更为常见(20%-40%)。HNF-1α基因位于12号染色体长臂(12q)上。HNF-1β(位于17号染色体长臂的MODY5位点)是一种能与HNF-1α形成异源二聚体的蛋白质。这种罕见的糖尿病类型临床表现与MODY1和MODY3相似。有时还伴有独立于糖尿病的早期肾脏损害症状。另外两种导致常染色体显性2型糖尿病的转录因子是直接与胰岛素启动子结合的蛋白质。MODY4(IPF-1,位于13号染色体长臂)是一种罕见的典型中晚期发病的2型糖尿病。美国马萨诸塞州波士顿乔斯林糖尿病中心的Krolewski博士团队最近发现BETA 2/Neurod1与MODY有关。BETA 2导致约2%的常染色体显性2型糖尿病。其临床特征取决于蛋白质特定功能域中突变的位置。在葡萄糖激酶基因中发现的突变与MODY2有关。葡萄糖激酶是一种参与β细胞内葡萄糖代谢第一阶段(酶促磷酸化)的酶。MODY2是一种症状较轻的糖尿病类型。其特点是轻度高血糖,主要为空腹血糖升高,慢性并发症非常罕见。葡萄糖激酶基因位于7号染色体短臂(7p)上。预计在不久的将来会发现更多的2型糖尿病易感基因。